Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients

Clinical trial NCT00319189 · COMPLETED

Trial details

NCT number: NCT00319189
Sponsor: University of Oslo School of Pharmacy
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Renal Transplant Recipients Posttransplant Diabetes Mellitus Posttransplant Impaired Glucose Tolerance

Start date: 2002-11-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.